Sama Abdulrazzaq1, Wahiba Elhag1, Walid El Ansari2,3,4, Amjad Salah Mohammad5, Davit Sargsyan6,7, Moataz Bashah6,7. 1. Department of Bariatric Surgery/Bariatric Medicine, Hamad General Hospital, 3050, Doha, Qatar. 2. Department of Surgery, Hamad General Hospital, 3050, Doha, Qatar. welansari9@gmail.com. 3. College of Medicine, Qatar University, Doha, Qatar. welansari9@gmail.com. 4. Schools of Health and Education, University of Skovde, Skövde, Sweden. welansari9@gmail.com. 5. Departments of General Surgery, Hamad General Hospital, 3050, Doha, Qatar. 6. Department of Metabolic and Bariatric Surgery, Hamad General Hospital, 3050, Doha, Qatar. 7. Weill Cornell Medicine-Qatar, Doha, Qatar.
Abstract
BACKGROUND: Revisional gastric bypass (R-RYGB) surgery is utilized for the management of inadequate weight loss or weight regain observed after some cases of bariatric surgeries. Data on the mid-term effectiveness of primary gastric bypass (P-RYGB) compared with R-RYGB (e.g., post sleeve gastrectomy/gastric banding) are controversial. METHODS: Retrospective chart review of all patients who received P-RYGB and R-RYGB (January 2011-June 2015) at our center. One hundred twenty patients who underwent P-RYGB and 34 R-RYGB who completed 18 months follow-up were included. We compared the effectiveness of P-RYGB with R-RYGB by assessing four anthropometric, two glycemic, and four lipid parameters, as well as the control of type 2 diabetes (T2DM), hypertension, dyslipidemia (remission, improvement, persistence, relapse, de novo), mortality and complications rates. RESULTS: A comparison of the effectiveness of P-RYGB with R-RYGB at 18 months revealed no significant differences in patients' age, gender, and preoperative BMI between groups. However, patients who received P-RYGB had lower mean weight (P = 0.001) and BMI (P < 0.001), reflected by a higher mean delta BMI (P = 0.02), total weight loss percentage (TWL%) (P < 0.0001) and excess weight loss percentage (EWL%) (P < 0.0001). No differences in glycemic parameters, lipid profiles, control of T2DM, hypertension, and dyslipidemia were observed. No death is reported and complication rates were comparable. CONCLUSIONS: Although R-RYGB effectively addressed inadequate weight loss, weight regain, and recurrence of comorbidities after restrictive bariatric surgery, R-RYGB resulted in inferior weight loss compared with P-RYGB. Neither procedure differed in their clinical control of T2DM, hypertension, and dyslipidemia. Both procedures exhibited comparable complication rates.
BACKGROUND: Revisional gastric bypass (R-RYGB) surgery is utilized for the management of inadequate weight loss or weight regain observed after some cases of bariatric surgeries. Data on the mid-term effectiveness of primary gastric bypass (P-RYGB) compared with R-RYGB (e.g., post sleeve gastrectomy/gastric banding) are controversial. METHODS: Retrospective chart review of all patients who received P-RYGB and R-RYGB (January 2011-June 2015) at our center. One hundred twenty patients who underwent P-RYGB and 34 R-RYGB who completed 18 months follow-up were included. We compared the effectiveness of P-RYGB with R-RYGB by assessing four anthropometric, two glycemic, and four lipid parameters, as well as the control of type 2 diabetes (T2DM), hypertension, dyslipidemia (remission, improvement, persistence, relapse, de novo), mortality and complications rates. RESULTS: A comparison of the effectiveness of P-RYGB with R-RYGB at 18 months revealed no significant differences in patients' age, gender, and preoperative BMI between groups. However, patients who received P-RYGB had lower mean weight (P = 0.001) and BMI (P < 0.001), reflected by a higher mean delta BMI (P = 0.02), total weight loss percentage (TWL%) (P < 0.0001) and excess weight loss percentage (EWL%) (P < 0.0001). No differences in glycemic parameters, lipid profiles, control of T2DM, hypertension, and dyslipidemia were observed. No death is reported and complication rates were comparable. CONCLUSIONS: Although R-RYGB effectively addressed inadequate weight loss, weight regain, and recurrence of comorbidities after restrictive bariatric surgery, R-RYGB resulted in inferior weight loss compared with P-RYGB. Neither procedure differed in their clinical control of T2DM, hypertension, and dyslipidemia. Both procedures exhibited comparable complication rates.
Entities:
Keywords:
Dyslipidemia; Hypertension; Primary gastric bypass; Revisional gastric bypass; Type 2 diabetes; Weight loss outcome
Authors: Lars Sjöström; Anna-Karin Lindroos; Markku Peltonen; Jarl Torgerson; Claude Bouchard; Björn Carlsson; Sven Dahlgren; Bo Larsson; Kristina Narbro; Carl David Sjöström; Marianne Sullivan; Hans Wedel Journal: N Engl J Med Date: 2004-12-23 Impact factor: 91.245
Authors: E O Aarts; K Dogan; P Koehestanie; Th J Aufenacker; I M C Janssen; F J Berends Journal: Surg Obes Relat Dis Date: 2014-04-05 Impact factor: 4.734
Authors: Kamal K Mahawar; Yitka Graham; William R J Carr; Neil Jennings; Norbert Schroeder; Shlok Balupuri; Peter K Small Journal: Obes Surg Date: 2015-07 Impact factor: 4.129
Authors: Elemer Mohos; Zoltán Jánó; Doris Richter; Elizabeth Schmaldienst; Gábor Sándor; Petra Mohos; Miroslav Horzov; Gábor Tornai; Manfred Prager Journal: Obes Surg Date: 2014-12 Impact factor: 4.129
Authors: Antoine Vallois; Benjamin Menahem; Yannick Le Roux; Adrien Lee Bion; Hugo Meunier; Thomas Gautier; Nicolas Contival; Andrea Mulliri; Jean Lubrano; Jean-Jacques Parienti; A Alves Journal: Obes Surg Date: 2019-03 Impact factor: 4.129
Authors: Anne-Sophie van Rijswijk; Nienke van Olst; Winnie Schats; Donald L van der Peet; Arnold W van de Laar Journal: Obes Surg Date: 2021-05-17 Impact factor: 4.129
Authors: Catarina Osório; Diogo Silva; Marta Guimarães; Rui F Almeida; António Reis; Samuel Cardoso; Sofia S Pereira; Mariana P Monteiro; Mário Nora Journal: Obes Surg Date: 2021-05-22 Impact factor: 4.129